KR102120323B1 - Composition for hepatoprotective or ameliorating hangover containing herbal extract and edible insect enzyme-decomposed with enzyme - Google Patents

Composition for hepatoprotective or ameliorating hangover containing herbal extract and edible insect enzyme-decomposed with enzyme Download PDF

Info

Publication number
KR102120323B1
KR102120323B1 KR1020190152440A KR20190152440A KR102120323B1 KR 102120323 B1 KR102120323 B1 KR 102120323B1 KR 1020190152440 A KR1020190152440 A KR 1020190152440A KR 20190152440 A KR20190152440 A KR 20190152440A KR 102120323 B1 KR102120323 B1 KR 102120323B1
Authority
KR
South Korea
Prior art keywords
extract
weight
parts
enzyme
composition
Prior art date
Application number
KR1020190152440A
Other languages
Korean (ko)
Inventor
정명수
이종철
김성태
이민호
유수인
강지희
김안나
정원영
이정연
정주영
김근현
Original Assignee
주식회사 한미양행
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 한미양행 filed Critical 주식회사 한미양행
Priority to KR1020190152440A priority Critical patent/KR102120323B1/en
Application granted granted Critical
Publication of KR102120323B1 publication Critical patent/KR102120323B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L35/00Food or foodstuffs not provided for in groups A23L5/00 – A23L33/00; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/334Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

The present invention relates to a composition containing extracts of composition enzyme-decomposed mealworms, enzyme-decomposed Protaetia brevitarsis seulensis (Kolbe) larvae, enzyme-decomposed crickets, a matured pumpkin extract, a cinnamon extract, a Citrus unshiu Markovich peel extract, an Astragalus membranaceus Bunge extract, a fermented Green flesh black bean extract, a Lepidium meyenii extract, a ginseng flower bud extract, a grape extract, and a Scutellaria baicalensis Georgi extract. According to the present invention, the composition provides excellent hangover relief due to activity increase of alcohol decomposition enzyme and mitigates hepatoxicity caused by alcohol, thereby being easily used as a treatment composition for various kinds of diseases, such as alcoholic hepatitis and alcohol fatty liver related to liver damage and health function food for preventing and mitigating the diseases.

Description

식용곤충 효소처리물 및 생약 추출물을 함유하는 숙취해소 또는 간보호용 조성물 {Composition for hepatoprotective or ameliorating hangover containing herbal extract and edible insect enzyme-decomposed with enzyme}Composition for hepatoprotective or ameliorating hangover containing herbal extract and edible insect enzyme-decomposed with enzyme}

본 발명은 식용곤충 효소처리물 및 생약 추출물을 함유하는 숙취해소 또는 간보호용 조성물에 관한 것으로서, 보다 자세하게는 갈색거저리 유충 효소처리물, 흰점박이꽃무지 유충 효소처리물, 귀뚜라미 성충 효소처리물, 늙은호박 추출물, 계피추출물, 진피 추출물, 황기 추출물, 발아서리태 추출물, 마카 추출물, 인삼화뢰 추출물, 포도 추출물, 황금추출물을 함유하는 숙취해소 또는 간보호용 조성물에 관한 것이다. The present invention relates to a composition for relieving hangover or liver protection containing an edible insect enzyme treatment and a herbal extract, more specifically, a brown larva larva enzyme treatment, a white spotted flower larva larva enzyme treatment, a cricket adult enzyme treatment, an old Pumpkin extract, cinnamon extract, dermis extract, astragalus extract, germinated frost extract, maca extract, ginseng torpedo extract, grape extract, relates to a composition for relieving hangover or protecting liver containing golden extract.

간 질환은 주로 만성적인 음주에 의해 발생하는 여러 가지 간의 질환을 말하는데 형태에 따라 알코올성 지방간, 알코올성 간염, 알코올성 간경변으로 크게 나누어지지만 한 사람에게서 순수한 한 가지 병만 나타나는 경우는 드물고, 각 병이 개인마다 다양한 정도로 나타나게 된다. Liver disease mainly refers to various liver diseases caused by chronic drinking. It is largely divided into alcoholic fatty liver, alcoholic hepatitis, and alcoholic cirrhosis, depending on the type, but it is rare that only one disease occurs in one person, and each disease varies from person to person. Will appear.

건겅보험심사평가원 통계에 따르면 최근 국내 알코올성 간질환으로 발생되는 치료비용은 매년 급증하는 증가추세다. 또한 국내 한 생명보험사의 통계를 분석해 봐도 시망원인 중 알코올성 간질환 사망자가 10년 전과 비교해 7배로 급증했다.According to statistics from the Health Insurance Review and Assessment Service, treatment costs incurred by domestic alcoholic liver disease have been increasing rapidly every year. In addition, when analyzing the statistics of a domestic life insurance company, the number of deaths from alcoholic liver disease among the causes of skyrocketing has increased seven times compared to 10 years ago.

지속적인 알코올 섭취로 인해 유발되는 알코올성 간질환은 국내를 비롯한 전 세계적인 사회적인 문제로 대두되고 있다. 특히 알코올성 지방간 및 간염이 지속되면 간섬유화 및 간경변으로 더 이상 회복을 기대할 수 없는 단계에 이르게 되어 간 이식만이 유일한 치료방법으로 남게 되었다. Alcoholic liver disease caused by continuous alcohol consumption has emerged as a social problem worldwide, including in Korea. In particular, if alcoholic fatty liver and hepatitis persist, liver fibrosis and cirrhosis can no longer be expected to recover, and liver transplantation remains the only treatment.

우리나라의 경우 20세 이상 성인 남자의 음주율은 83.3%로 매우 높고 여성의 음주율 또한 54.9%로 급격히 증가하는 추세이며, 잘못 된 음주 문화로 인하여 과음에 심각하게 노출되어 있다. 알코올의 과다 섭취로 인한 피해는 간질환을 비롯하여 각종 질환의 병인이 됨은 물론 개인, 가정, 사회의 정서와 생활에 부정적인 영향을 미침으로써 국가적으로 막대한 경제, 사회적 손실을 야기하고 있다. In Korea, the drinking rate of adult males over the age of 20 is 83.3%, and the drinking rate of women is also rapidly increasing to 54.9%, and it is severely exposed to excessive drinking due to the wrong drinking culture. The damage caused by excessive consumption of alcohol not only causes etiology of various diseases including liver disease, but also negatively affects the emotions and lives of individuals, families, and society, causing great economic and social loss in the country.

지나친 과음을 통해 나타나는 여러 형태의 부작용 중 숙취는 갈증, 전신권태, 피로감, 기억상실, 복부팽만감, 소화불량, 구토, 설사 등의 현상으로 나타난다. Among the various types of side effects caused by excessive drinking, hangover is a symptom of thirst, general boredom, fatigue, memory loss, bloating, indigestion, vomiting, and diarrhea.

정상적인 알코올 대사과정은 알코올이 섭취되는 경우, 위장, 또는 소장에서 흡수되어 그 중 10%는 호흡, 땀, 소변 등으로 배설되고, 나머지 90%의 알코올은 혈관 중에 들어가 간에서 대사된다(M. Nakanishi; Saishin Igaku, 31, p2086, 1976). 이어서 간세포에 존재하는 알코올 탈수소효소(alcohol dehydrogenase, ADH)가 알코올을 아세트알데하이드로 산화시키고, 아세트알데하이드는 간세포에서 아세트알데하이드 탈수소효소(acetaldehyde dehydrogenase)에 의하여 아세트산으로 분해되어 전신의 근육이나 지방 조직으로 옮겨서 최종적으로는 탄산가스와 물로 분해된다. 그러나 이러한 분해 대사과정에서 과음으로 인해 속쓰림이 발생하고, 알코올 대사의 이상이 오며 혈중 알코올 농도가 높아지면서 대사되지 못한 에틸알코올이나 아세트알데하이드 등으로 인해 뇌혈관 수축이 일어나 두통, 어지럼증 등이 발생한다. Normal alcohol metabolism is absorbed from the stomach or small intestine when alcohol is ingested, 10% of which is excreted in breath, sweat, and urine, and the remaining 90% of alcohol enters blood vessels and is metabolized in the liver (M. Nakanishi ; Saishin Igaku, 31, p2086, 1976). Subsequently, alcohol dehydrogenase (ADH) present in the liver cells oxidizes the alcohol to acetaldehyde, and acetaldehyde is broken down into acetic acid by acetaldehyde dehydrogenase in the liver cells and transferred to the muscles or adipose tissue of the whole body. Finally, it is decomposed into carbon dioxide gas and water. However, in this decomposition metabolic process, heartburn occurs due to excessive drinking, abnormal alcohol metabolism occurs, and as the alcohol concentration in the blood increases, cerebral blood vessel contraction occurs due to unproduced ethyl alcohol or acetaldehyde, resulting in headache and dizziness.

숙취해소제는 이와같이 과음에서 유래될 수 있는 갈증, 전신권태, 피로감, 기억상실, 복부팽만감, 소화불량, 구토, 설사 등에 다각적으로 효능이 인정되면서 복용에 거부감이 없고 및 휴대가 용이한 형태의 제품개발이 필요할 것으로 보인다. The hangover reliever has various effects such as thirst, systemic boredom, fatigue, memory loss, abdominal distension, indigestion, vomiting, diarrhea, etc., which can result from excessive drinking. Development seems to be needed.

그러나 대개의 숙취해소제품들은 생약재를 소재로하여 개발되어 있기 때문에 한액취 및 이취가 강하여 복용에 거부감이 있어 이에 대한 연구가 필요하다. 한약취 및 이취 등의 감소방법으로는 효소처리 등 생물학적 방법, 향료 등에 의한 마스킹 등의 화학적 방법 및 가온숙성 등의 물리적 방법이 있을 수 있다. However, since most hangover-relieving products are developed from herbal ingredients, there is a strong sense of odor and odor, so research on this is necessary. Reduction methods such as herbal medicine and odor may include biological methods such as enzyme treatment, chemical methods such as masking with fragrances, and physical methods such as warming.

물리적 방법에 대한 예로는 저온숙성된 천년목란 추출물(대한민국 등록특허 제10-1948661호), 숙성율피 또는 그의 추출물(대한민국 등록특허 제10-1881369호), 가온 숙성대추를 이용한 양갱(대한민국 공개특허 제10-2015-0075838호), 홍산과 녹용 추출물을 중탕기에서 그대로 8 내지 14시간 방치하여 숙성단계를 거친 것을 함유하는 홍삼 및 녹용 추출물을 포함하는 드링크제 및 그의 제조방법(대한민국 등록특허 제10-1090284호), 열처리에 의한 홍삼엑기스 성분변화(농화학회지 24(1): 51-58, 1980), 열처리에 의한 홍삼엑기스의 색상변화(고려인삼학회지 4(2):50-58, 1981) 등이 있다. Examples of physical methods include cold aged cheonnyeonmokran extract (Republic of Korea Patent No. 10-1948661), maturing rate or its extract (Republic of Korea Patent Registration No. 10-1881369), yanggang using warm ripened jujube (Korea Patent Publication No. 10-2015-0075838), a drink agent containing red ginseng and antler extract containing red ginseng and deer antler extracts that have been subjected to an aging step by leaving them for 8 to 14 hours as they are in a boiling water bath and a method of manufacturing the same (Korea Patent Registration No. 10-1090284) ), red ginseng extract composition change by heat treatment (Agrochemical Journal 24(1): 51-58, 1980), color change of red ginseng extract by heat treatment (Korea Ginseng Society 4(2):50-58, 1981). .

또한, 숙취해소에 대해서는 대한민국 등록특허 제10-0552398호(작두콩 추출물을 함유하는 숙취해소용 음료 조성물), 대한민국 등록특허 제10-0989869호(콩나물 발효액을 함유하는 숙취해소 음료), 대한민국 등록특허 제10-1601947호(땅콩새싹 추출물 및 울금추출물을 함유하는 숙취해소 음료 조성물), 대한민국 공개특허 제10-2002-0081995호(배합식품에 의한 숙취해소 및 간 기능 개선제와 그 제조방법), 대한민국 공개특허 제10-2002-0064151호(헛개나무로부터 분리된 간독성 및 숙취해소 활성을 갖는 저급알코올 불용성 추출 분획 및 다당체 물질 및 이를 함유하는 조성물) 등의 특허를 비롯한 쌀눈엑스(구루메), 오리나무, 참나무 목초액, 갈화, 밀크씨슬 추출물 등의 여러 가지 식물에서 기원한 제제들이 숙취에 효능이 있다고 보고되어 있다. 그러나 이들 제품은 실제 만들어진 최종 완제품의 효능에 대하여 객관적 검증이 미흡한 상황으로 실제 숙취해소 제품을 필요로 하는 소비자들에게 신뢰도가 높지 않은 것이 사실이다. 이에 숙취해소 효능의 검증을 통해서 실제 소비자들이 신뢰할 수 있고 과다한 음주로 인한 사회적 손실을 줄이면서도 더불어 개인의 건강한 생활에도 도움을 줄 수 있는 제품개발이 절실히 요구되고 있다.In addition, for the hangover cancellation, the Republic of Korea Patent No. 10-0552398 (a beverage composition for hangover cancellation containing pea extract), Republic of Korea Patent No. 10-0989869 (hangover cancellation beverage containing fermented soybean sprouts), Korea Registered Patent No. 10-1601947 (a hangover-relieving beverage composition containing peanut sprout extract and turmeric extract), Republic of Korea Patent Publication No. 10-2002-0081995 (hangover-relieving by blended foods and liver function improving agent and its manufacturing method), Republic of Korea Patent No. 10-2002-0064151 (low-alcohol insoluble extract fraction with hepatotoxicity and hangover-removing activity isolated from huts and polysaccharide substances and compositions containing the same), including rice bran extract (Gurume), alder, and oak grasses , Originated from various plants, such as galaxies and milk thistle extract, have been reported to be effective in hangovers. However, it is true that these products have insufficient objective verification of the efficacy of the final product, which is actually made, and are not highly reliable for consumers who need a product to cure hangovers. Accordingly, it is urgently needed to develop products that can help consumers to have a healthy life by trusting and reducing social losses due to excessive drinking by verifying efficacy of hangover relief.

이와 같은 배경 하에서, 본 발명자들은 보다 효과적으로 숙취를 해소할 수 있는 방법을 개발하고자 노력한 결과 곤충 효소처리물 및 생약 추출물의 혼합물이 혈중 알코올 농도의 수준을 효과적으로 감소시키면서 숙취해소에 효과가 있을 뿐만 아니라 간보호 효과가 있음을 확인하여 본 발명을 완성하였다. Under such a background, the present inventors tried to develop a method that can more effectively relieve hangovers. As a result, a mixture of insect enzyme treatments and herbal extracts effectively reduces the level of alcohol concentration in the blood and is effective in relieving hangovers as well as liver. The present invention was completed by confirming that there is a protective effect.

대한민국 등록특허 제10-0477957호 (발명의 명칭 : 구기자로부터 분리된 간 보호활성을 갖는 신규 피롤유도체 및 이를 함유한 조성물, 출원인 : 재단법인서울대학교산학협력재단, 등록일 : 2005년03월10일)Republic of Korea Registered Patent No. 10-0477957 (Invention name: New pyrrole derivative having liver protective activity separated from wolfberry and composition containing the same, Applicant: Seoul National University Industry-Academic Cooperation Foundation, Registration Date: March 10, 2005) 대한민국 등록특허 제10-0633851호 (발명의 명칭 : 가열건조처리 된 산마늘 추출물을 유효성분으로 함유하는 간 보호 또는 간질환의 예방 및 치료용 조성물, 출원인 : 학교법인 상지학원, 등록일 : 2006년10월04일)Republic of Korea Registered Patent No. 10-0633851 (Invention name: Composition for prevention and treatment of liver disease or liver disease containing heat-dried acid garlic extract as an active ingredient, Applicant: School Corporation Sangji Academy, Registration Date: October 2006 April 04) 대한민국 등록특허 제10-1106499호 (발명의 명칭 : 헛개나무 어린가지 추출물을 포함하는 간보호 효과용 식품 조성물, 출원인 : 장흥군, 등록일 : 2012년01월10일)Republic of Korea Registered Patent No. 10-1106499 (Invention name: Food composition for hepatoprotective effect including the extract of young tree bran, Applicant: Jangheung-gun, Registration date: January 10, 2012) 대한민국 등록특허 제10-1852840호 (발명의 명칭 : 굼벵이 효소처리물을 함유하는 간 보호용 조성물, 출원인 : 주식회사 한미양행, 등록일 : 2018년04월23일)Republic of Korea Registered Patent No. 10-1852840 (Invention name: Composition for liver protection containing slug enzyme treatment, Applicant: Hanmi Corporation, Registration Date: April 23, 2018) 대한민국 등록특허 제10-1919839호 (발명의 명칭 : 귀뚜라미 효소처리물을 함유하는 간보호 또는 숙취해소용 조성물, 출원인 : 주식회사 한미양행, 등록일 : 2018년2018년11월13일)Republic of Korea Registered Patent No. 10-1919839 (Invention name: Composition for liver protection or hangover elimination containing cricket enzyme treatment, Applicant: Hanmi Corporation, Registration Date: November 13, 2018) 대한민국 등록특허 제10-0453575호 (발명의 명칭 : 귀뚜라미 자체 또는 이의 추출물을 함유하는 간보호, 강장피로회복, 알코올대사 촉진, 과산화지질 생성 억제를 위한 식품조성물, 출원인 : 대한민국, 등록일 : 2004년10월11일)Republic of Korea Registered Patent No. 10-0453575 (Invention name: Cricket itself or liver extract containing its extract, tonic fatigue recovery, alcohol metabolism promotion, food composition for inhibiting lipid peroxide production, Applicant: Republic of Korea, Registration Date: October 2004 May 11) 대한민국 공개특허 제10-2002-0081995호 (발명의 명칭 : 배합식품에 의한 숙취해소 및 간 기능 개선제와 그 제조방법, 출원인 : (주)드리고, 공개일 : 2002년 10월 30일)Republic of Korea Patent Publication No. 10-2002-0081995 (Invention name: Relieving hangover by blended foods and liver function improving agent and its manufacturing method, Applicant: Dear Co., Ltd., Publication date: October 30, 2002) 대한민국 공개특허 제10-2002-0064151호 (발명의 명칭 : 헛개나무로부터 분리된 간독성 및 숙취해소 활성을 갖는 저급알코올 불용성 추출 분획 및 다당체 물질 및 이를 함유하는 조성물, 출원인 : 농업회사 법인 주식회사 생명의나무, 공개일 : 2002년08월07일)Republic of Korea Patent Publication No. 10-2002-0064151 (Invention name: low-alcohol insoluble extract fraction and polysaccharide substance having hepatotoxicity and hangover-removing activity isolated from hut tree, and composition containing the same, Applicant: Tree of Life, Ltd. , Release date: August 7, 2002) 대한민국 등록특허 제10-1948661호 (발명의 명칭 : 대나무 숯을 이용하여 저온 숙성된 천녀목란 추출물을 유효성분으로 포함하는 피부 미백용 화장료 조성물, 출원인 : 주식회사 코리아나화장품, 등록일 : 2019년02월11일)Republic of Korea Registered Patent No. 10-1948661 (Invention name: Cosmetic composition for skin whitening, which contains low-temperature aged Cheonnyeonmolan extract using bamboo charcoal as an active ingredient, Applicant: Koreana Cosmetics Co., Ltd., Registration Date: February 11, 2019 ) 대한민국 등록특허 제10-1881369호 (발명의 명칭 : 항산화성 숙성율피 및 숙성율피 또는 그의 추출물을 유효성분으로 포함하는 항산화 조성물, 출원인 : 충남대학교산학협력단, 등록일 : 2018년07월18일)Republic of Korea Registered Patent No. 10-1881369 (Invention name: Antioxidant aging rate skin and antioxidant composition comprising aging rate skin or extracts thereof as an active ingredient, Applicant: Chungnam National University Industry-Academic Cooperation Foundation, Registration Date: July 18, 2018) 대한민국 공개특허 제10-2015-0075838호 (발명의 명칭 : 가온 숙성대추를 이용한 양갱 및 그 제조방법, 출원인 : 권오성, 공개일 : 2015년07월06일)Republic of Korea Patent Publication No. 10-2015-0075838 (Invention name: yanggang using warm aging jujube and its manufacturing method, Applicant: Kwon Oh-sung, Publication date: July 6, 2015) 대한민국 등록특허 제10-1090284호 (발명의 명칭 : 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법, 출원인 : 김진, 등록일 : 2011년11월30일)Republic of Korea Registered Patent No. 10-1090284 (Invention name: Drink agent containing red ginseng and antler extract and manufacturing method thereof, Applicant: Jin Kim, Registration date: November 30, 2011)

본 발명의 목적은 식용곤충 효소처리물 및 생약 추출물을 함유하는 숙취해소 또는 간보호용 조성물을 제공하는 것으로서, 보다 자세하게는 갈색거저리 유충 효소처리물, 흰점박이꽃무지 유충 효소처리물, 귀뚜라미 성충 효소처리물, 늙은호박 추출물, 계피추출물, 진피 추출물, 황기 추출물, 발아서리태 추출물, 마카 추출물, 인삼화뢰 추출물, 포도 추출물, 황금추출물을 함유하는 숙취해소 또는 간보호용 조성물을 제공하는 데에 있다. An object of the present invention is to provide a composition for resolving hangover or protecting the liver containing an edible insect enzyme treatment and a herbal extract, more specifically, a brown larva larva enzyme treatment, a white spotted flower larva larva enzyme treatment, a cricket adult treatment Water, old pumpkin extract, cinnamon extract, dermis extract, astragalus extract, germinated frost extract, maca extract, ginseng torpedo extract, grape extract, to provide a composition for relieving hangover or protecting liver containing golden extract.

본 발명은 갈색거저리 유충 효소처리물, 흰점박이꽃무지 유충 효소처리물, 귀뚜라미 성충 효소처리물, 늙은호박 추출물, 계피추출물, 진피 추출물, 황기 추출물, 발아서리태 추출물, 마카 추출물, 인삼화뢰 추출물, 포도 추출물 및 황금추출물을 함유하는 숙취해소 또는 간보호용 조성물에 관한 것이다. The present invention is a brown larva larvae enzymatic treatment, white spotted flower radish larvae enzymatic treatment, cricket adult enzymatic treatment, old pumpkin extract, cinnamon extract, dermis extract, astragalus extract, germinated frost extract, maca extract, ginseng lightning extract, grapes The present invention relates to a composition for relieving hangover or protecting the liver containing an extract and a golden extract.

보다 바람직하게는 상기 조성물에는 갈색거저리 유충 효소처리물 100 중량부 기준으로, 흰점박이꽃무지 유충 효소처리물 20~40 중량부, 귀뚜라미 성충 효소처리물 20~40 중량부, 늙은호박 추출물 50~80 중량부, 계피 추출물 30~110 중량부, 진피 추출물 70~150 중량부, 황기 추출물 30~100 중량부, 발아서리태 추출물 120~150 중량부, 마카 추출물 40~90 중량부, 인삼화뢰 추출물 100~150 중량부, 포도 추출물 30~100 중량부 및 황금 추출물 2~50 중량부가 포함될 수 있다. 이 때 각 곤충의 효소처리물이나 각 추출물들의 혼합이 이와 같은 혼합비를 벗어날 경우 숙취해소 또는 간보호 효능이 저하될 수 있어 바람직하지 않다. More preferably, the composition is based on 100 parts by weight of the brown larva larvae enzyme treatment, 20 to 40 parts by weight of white spotted flower larvae larvae enzyme treatment, 20 to 40 parts by weight of cricket adult enzyme treatment, 50 to 80 years old pumpkin extract Parts by weight, cinnamon extract 30-110 parts by weight, dermis extract 70-150 parts by weight, astragalus extract 30-100 parts by weight, germination frost extract 120-150 parts by weight, maca extract 40-90 parts by weight, ginseng lightning extract 100-150 It may contain parts by weight, 30 to 100 parts by weight of grape extract, and 2 to 50 parts by weight of golden extract. At this time, if the mixture of enzyme treatments or extracts of each insect deviates from the mixing ratio, it is not preferable because it can reduce hangover or reduce liver protection.

또한, 상기 조성물에는 헛개열매 추출물, 울금 추출물, 갈근 추출물, 엉겅퀴 추출물, 포공영 추출물, 쑥 추출물, 사과 추출물, 감초 추출물, 대추 추출물, 아스파라긴산, 액상과당, 무수구연산, 비타민 C, 타우린, 젖산칼슘, L-아르기닌, 구연산삼나트륨, 니코틴산아미드, 효소처리스테비아, 비타민 B1 염산염, 비타민 B2 및 DL-알파-토코페릴초산염이 더 포함될 수 있고, 적량의 정제수가 함유될 수 있는데,In addition, the composition includes baekgae fruit extract, turmeric extract, root extract, thistle extract, pogongyoung extract, mugwort extract, apple extract, licorice extract, jujube extract, aspartic acid, liquid fructose, citric anhydride, vitamin C, taurine, calcium lactate, L -Arginine, trisodium citrate, nicotinic acid amide, enzymatic treatment stevia, vitamin B1 hydrochloride, vitamin B2 and DL-alpha-tocopheryl acetate may be further included, and an appropriate amount of purified water may be contained.

보다 바람직하게는, More preferably,

갈색거저리 유충 효소처리물 100 중량부 기준으로, 헛개열매 추출물 250~400 중량부, 울금 추출물 50~100 중량부, 갈근 추출물 50~100 중량부, 엉겅퀴 추출물 50~100 중량부, 포공영 추출물 50~100 중량부, 쑥 추출물 50~100 중량부, 사과 추출물 200~300 중량부, 감초 추출물 5~20 중량부, 대추 추출물 5~20 중량부, 아스파라긴산 50~100 중량부, 액상과당 3000~4000 중량부, 무수구연산 100~200 중량부, 비타민C 30~70 중량부, 타우린 20~50 중량부, 젖산칼슘 20~40 중량부, L-아르기닌 10~30 중량부, 구연산삼나트륨 5~20 중량부, 니코틴산아미드 5~20 중량부, 효소처리스테비아 1~5 중량부, 비타민B1염산염 1~3 중량부, 비타민B2 1~3 중량부 및 DL-알파-토코페릴초산염 1~3 중량부가 포함되는 것이 좋다. Based on 100 parts by weight of the enzyme treatment of brown larvae, 250 to 400 parts by weight of oyster fruit extract, 50 to 100 parts by weight of turmeric extract, 50 to 100 parts by weight of extract of brown root, 50 to 100 parts by weight of thistle extract, 50 to 100 parts of pogongyoung extract Parts by weight, mugwort extract 50-100 parts by weight, apple extract 200-300 parts by weight, licorice extract 5-20 parts by weight, jujube extract 5-20 parts by weight, aspartic acid 50-100 parts by weight, liquid fructose 3000-4000 parts by weight, 100 to 200 parts by weight of citric anhydride, 30 to 70 parts by weight of vitamin C, 20 to 50 parts by weight of taurine, 20 to 40 parts by weight of calcium lactate, 10 to 30 parts by weight of L-arginine, 5 to 20 parts by weight of trisodium citrate, nicotinic acid It is preferable that 5 to 20 parts by weight of amide, 1 to 5 parts by weight of enzyme-treated stevia, 1 to 3 parts by weight of vitamin B1 hydrochloride, 1 to 3 parts by weight of vitamin B2 and 1 to 3 parts by weight of DL-alpha-tocopheryl acetate are included.

상기 조성물에는 정제수(물)가 적량 함유될 수 있는데, 갈색거저리 유충 효소처리물 100 중량부 기준으로, 정제수 20000~50000 중량부가 함유될 수 있다. The composition may contain an appropriate amount of purified water (water), based on 100 parts by weight of the brown larva larvae enzyme treatment, may contain 20000 to 50000 parts by weight of purified water.

본 발명의 조성물에 사용되는 추출물 원료 중 발아서리태는 발아콩 추출물은 콩발아 자엽, 콩발아 배 및 콩발아 뿌리에서 선택되는 것일 수 있고, 발아콩자엽 및 발아콩 배와 발아콩 뿌리 전체일 수도 있다.Of the extract raw materials used in the composition of the present invention, germinated bean extract may be selected from soybean sprout cotyledons, soybean germinated pears and soybean germinated roots, and may also be germinated soybean cotyledons and germinated bean pears and whole germinated bean roots. .

본 발명은 상기 조성물을 함유하는 알코올성 간질환의 예방, 개선 또는 치료용 약학조성물과 건강기능식품을 제공한다. 상기 알코올성 간질환은 알코올성 간염, 알코올성 지방간 또는 알코올성 간경변일 수 있다. The present invention provides a pharmaceutical composition and a health functional food for preventing, improving or treating alcoholic liver disease containing the composition. The alcoholic liver disease may be alcoholic hepatitis, alcoholic fatty liver or alcoholic cirrhosis.

본 발명에서 사용하는 식용곤충 효소처리물은 원료 곤충에 플라보자임(Flavozyme), 알킬라아제(Alcalase) 또는 프로테아제(Protease) N에서 선택되는 효소를 처리한 것일 수 있는데, 알카라아제를 사용하는 것이 가장 바람직하다. The edible insect enzyme treatment used in the present invention may be a raw material insect treated with an enzyme selected from flavozyme, alkylase, or protease N. It is most preferred.

상기 식용곤충 효소처리물은 원료 식용곤충 100 중량부 기준 200~400 중량부의 정제수를 첨가한 후 100~150℃에서 0.5시간~2시간 동안 가열하고 40~60℃로 식힌 후, 5~10시간 동안 효소처리 된 것일 수 있다. 이 때, 원료 식용곤충 100 중량부 기준으로 효소를 0.1~10 중량부 첨가하는 것이 바람직하다.The edible insect enzyme treatment is added to 200 to 400 parts by weight of purified water based on 100 parts by weight of the raw edible insect, and then heated at 100 to 150°C for 0.5 to 2 hours, cooled to 40 to 60°C, and then for 5 to 10 hours. It may be enzymatically treated. At this time, it is preferable to add 0.1 to 10 parts by weight of enzyme based on 100 parts by weight of the raw material edible insect.

또한 효소처리 이 후, 이를 당도가 20~70 브릭스(Brix)가 되도록 농축할 수 있고 필요에 따라 분말화할 수 있으며, 농축 전 또는 후로 90~100℃에서 20~60분간 열처리하여 효소를 실활시킬 수 있다.In addition, after the enzymatic treatment, it can be concentrated to a sugar content of 20 to 70 Brix and powdered as needed, and the enzyme can be deactivated by heat treatment at 90 to 100° C. for 20 to 60 minutes before or after concentration. have.

또는 효소처리된 것을 농축 및 여과하여 얻은 액상을 건조할 수 있고, 효소처리된 직후 또는 농축 후, 각 원료 식용곤충으로부터 분리된 기름 성분을 층분리하여 제거할 수 있다.Alternatively, the liquid obtained by concentrating and filtering the enzyme-treated can be dried, and immediately after or after the enzymatic treatment, the oil component separated from the edible insect of each raw material can be separated by layer separation.

효소처리된 직후 또는 농축 후의 액상은 건조하여 분말화 할 수 있는데, 분무건조, 열풍건조, 동결건조 등의 통상의 건조법을 이용할 수 있다.The liquid phase immediately after the enzymatic treatment or after concentration can be dried and powdered, and conventional drying methods such as spray drying, hot air drying, and freeze drying can be used.

상기와 같은 효소처리시, 원료 식용곤충 100 중량부 기준으로 정제수가 200 중량부 미만이면 이후의 효소처리과정에서 효소가 과활성화 되어 단백분해된 조성물의 품질이 저하될 수 있으며, 정제수가 400 중량부를 초과하게 되면 역시 이후의 효소처리시 효소활성이 약해 단백분해가 잘 되지 않을 수 있다.During the enzyme treatment as described above, if the purified water is less than 200 parts by weight based on 100 parts by weight of the raw material edible insect, the enzyme may be overactivated in the subsequent enzymatic treatment process, and the quality of the proteolytic composition may deteriorate, and the purified water may contain 400 parts by weight. If exceeded, the enzyme activity is weak during subsequent enzymatic treatment, and proteolysis may not be performed well.

상기 가열 조건은 살균과정 및 곤충을 익히는 조건을 동시에 수행하는 역할을 하는데, 가열 온도가 100℃ 미만이면 살균 작용이 잘 일어나지 않을 수 있고, 가열 온도가 150℃를 초과하게 되면 단백질의 성상에 변화가 나타나 단백분 된 조성물의 품질이 저하될 수 있다. 마찬가지로 가열 조건이 0.5시간 미만이어도 살균이 잘 안 될 수 있으며, 가열 시간이 2시간을 초과하게 되면 단백질의 성상에 변화가 일어날 수 있다.The heating conditions serve to simultaneously perform the sterilization process and the conditions for ripening insects. If the heating temperature is less than 100°C, sterilization may not occur well, and when the heating temperature exceeds 150°C, the property of the protein changes. It appears that the quality of the proteinized composition may deteriorate. Likewise, even if the heating condition is less than 0.5 hours, sterilization may not be performed well, and when the heating time exceeds 2 hours, a property of the protein may change.

상기 효소 처리 온도가 40℃ 미만이면 효소활성이 거의 나타나지 않을 수 있고, 60℃를 초과하게 되면 효소가 실활되어 작용하지 않을 수 있다.When the enzyme treatment temperature is less than 40°C, enzymatic activity may hardly appear, and when it exceeds 60°C, the enzyme may be deactivated and may not function.

또한, 효소처리 과정에서, 원료 식용곤충 100 중량부 기준으로 효소를 0.1 중량부 미만으로 첨가하게 되면 효소활성이 거의 나타나지 않을 수 있고, 10 중량부를 초과하여 첨가하게 되는 것은 효소 사용에 대한 비용 면에서 바람직하지 않고 효소의 작용이 과하게 되어 최종 단백분해된 산물의 물성이 더 나빠질 수 있다.In addition, in the process of enzyme treatment, when the enzyme is added in an amount of less than 0.1 parts by weight based on 100 parts by weight of the raw material edible insect, the enzyme activity may hardly appear, and the addition of more than 10 parts by weight is in terms of the cost of using the enzyme. It is undesirable and the action of the enzyme is excessive and the properties of the final proteolytic product may be worse.

이때 원료 식용곤충은 금식하여 배설물을 완전하게 배출시킨 것을 사용하되, 생 것 상태로 정제수로 세척 후 정제수를 첨가한 뒤 가열하는 것이 좋고, 가열 과정이 충분히 수행된 후에는 이를 식힌 후 상기 식용곤충을 분쇄하고 효소처리하여 가수분해 과정을 수행하는 것이 바람직하다. At this time, the raw material edible insect is used to fast and discharge the feces completely, but after washing with purified water in a raw state, it is recommended to add purified water and heat it.After the heating process is sufficiently performed, the edible insect is cooled and then the edible insect It is preferred to perform a hydrolysis process by crushing and enzymatic treatment.

본 발명에서 사용하는 각 추출물은, 추출물 제조용 원료시료에 물, C1~C4 알코올 또는 이들의 혼합용액을 용매로 하여 추출할 수 있으며, 상기 C1~C4 알코올은 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올 및 이소부탄올로 이루어진 군에서 선택될 수 있다. 상기 용매는 바람직하게는 물 또는 에탄올의 50~70(v/v)% 수용액인 것이 더 좋다. Each extract used in the present invention can be extracted using water, C1 to C4 alcohol or a mixed solution thereof as a solvent in the raw material sample for preparing the extract, and the C1 to C4 alcohol is methanol, ethanol, propanol, isopropanol, butanol and It can be selected from the group consisting of isobutanol. The solvent is preferably 50 to 70 (v/v)% aqueous solution of water or ethanol.

또한 추출물의 제조시 사용되는 물, C1~C4 알코올 또는 이들의 혼합용액은 원료시료 사용 중량 기준 1~40배 부피(1kg 기준 1~40ℓ) 또는 1~40배 중량을 사용할 수 있으며, 바람직하게는 5~10배 부피 또는 5~10배 중량을 사용할 수 있다. In addition, water, C1 to C4 alcohol or a mixed solution thereof used in the preparation of the extract may be used in a volume of 1 to 40 times (1 to 40 liters per 1 kg) or 1 to 40 times weight based on the weight of the raw material sample used, preferably 5 to 10 times the volume or 5 to 10 times the weight can be used.

상기 추출물의 추출조건은 20~100℃에서 1분~48시간일 수 있다. 상기 과정은 1~4번까지 반복할 수 있다. 더 바람직하게는 80~95℃의 온도에서 5~8시간 추출한 뒤(가온과정), 추출액상만을 수거한 후 50~70℃에서 8~12시간 교반하는 과정(숙성과정)인 것이 더 좋다. 이 후 50~60℃에서 감압농축하여 상기 추출물을 20~70 브릭스의 농축물 상태로 제조할 수 있고 필요에 따라 분말화할 수 있다. Extraction conditions of the extract may be from 1 minute to 48 hours at 20 ~ 100 ℃. The above process can be repeated 1 to 4 times. More preferably, after extracting for 5 to 8 hours at a temperature of 80 to 95°C (heating process), it is better to collect only the extract liquid phase and then agitate for 8 to 12 hours at 50 to 70°C (aging process). Thereafter, the extract can be concentrated under reduced pressure at 50 to 60°C to prepare the extract in a concentrated state of 20 to 70 brix and powdered as necessary.

또한, 본 발명은 상기 조성물을 함유하는 알코올성 간질환의 예방 또는 치료용 약학 조성물을 제공한다. 상기 약학 조성물은, 각각 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸 등의 경구형 제형, 외용제, 좌제 및 멸균 주사용액의 형태로 제형화하여 사용될 수 있다. 상기 약학 조성물에 포함될 수 있는 담체, 부형제 및 희석제로는 락토즈, 덱스트로즈, 수크로스, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로즈, 메틸 셀룰로즈, 미정질 셀룰로스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유를 들 수 있다. 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 본 발명의 약학 조성물에 적어도 하나 이상의 부형제, 예를 들면, 전분, 탄산칼슘, 수크로스 또는 락토오스, 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제, 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜, 폴리에틸렌글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween) 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다. In addition, the present invention provides a pharmaceutical composition for the prevention or treatment of alcoholic liver disease containing the composition. The pharmaceutical composition may be formulated and used in the form of oral dosage forms, external preparations, suppositories, and sterile injectable solutions, such as powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols, etc., according to a conventional method. Carriers, excipients and diluents that can be included in the pharmaceutical composition include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, cellulose , Methyl cellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil. In the case of formulation, it is prepared using diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrating agents and surfactants. Solid preparations for oral administration include tablets, pills, powders, granules, capsules, etc. These solid preparations include at least one excipient in the pharmaceutical composition of the present invention, for example, starch, calcium carbonate, sucrose or lactose. It is prepared by mixing gelatin, etc. In addition, lubricants such as magnesium stearate and talc are used in addition to simple excipients. Liquid preparations for oral use include suspensions, intravenous solutions, emulsions, syrups, etc. In addition to water and liquid paraffin, which are commonly used diluents, various excipients, such as wetting agents, sweeteners, fragrances, and preservatives, can be included. . Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, lyophilized preparations, and suppositories. Non-aqueous solvents and suspensions may include propylene glycol, polyethylene glycol, vegetable oils such as olive oil, and injectable esters such as ethyl oleate. As a base for suppositories, witepsol, macrogol, tween 61, cacao butter, laurin butter, and glycerogelatin may be used.

본 발명의 약학 조성물의 투여량은 치료받을 대상의 연령, 성별, 체중과, 치료할 특정 질환 또는 병리 상태, 질환 또는 병리 상태의 심각도, 투여경로 및 처방자의 판단에 따라 달라질 것이다. 이러한 인자에 기초한 투여량 결정은 당업자의 수준 내에 있으며, 일반적으로 투여량은 0.01㎎/㎏/일 내지 대략 2000㎎/㎏/일의 범위이다. 더 바람직한 투여량은 1㎎/㎏/일 내지 500㎎/㎏/일이다. 투여는 하루에 한번 투여할 수도 있고, 수회 나누어 투여할 수도 있다. 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다. The dosage of the pharmaceutical composition of the present invention will vary depending on the age, gender, weight of the subject to be treated, the specific disease or pathology to be treated, the severity of the disease or pathology, the route of administration, and the judgment of the prescriber. Dosage determination based on these factors is within the level of those skilled in the art, and dosages generally range from 0.01 mg/kg/day to approximately 2000 mg/kg/day. A more preferred dosage is 1 mg/kg/day to 500 mg/kg/day. The administration may be administered once a day, or may be divided into several times. The above dosage does not limit the scope of the present invention in any way.

본 발명의 약학 조성물은 쥐, 가축, 인간 등의 포유동물에 다양한 경로로 투여될 수 있다. 투여의 모든 방식은 예상될 수 있는데, 예를 들면, 경구, 직장 또는 정맥, 근육, 피하, 자궁내 경막 또는 뇌혈관내 주사에 의해 투여될 수 있다. The pharmaceutical composition of the present invention can be administered to various mammals, such as rats, livestock, and humans. All modes of administration can be expected, for example, by oral, rectal or intravenous, intramuscular, subcutaneous, intrauterine dura mater or intracranial injection.

또한, 본 발명은 상기 조성물을 함유하는 식품학적으로 허용 가능한 식품보조 첨가제를 포함하는 조성물을 함유하는 알코올성 간질환의 예방 또는 개선용 건강기능식품을 제공한다. 본 발명의 건강기능식품은 정제, 캡슐제, 환제 또는 액제 등의 형태를 포함하며, 본 발명의 조성물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 드링크제, 육류, 소세지, 빵, 캔디류, 스넥류, 면류, 아이스크림, 유제품, 스프, 이온음료, 음료수, 알코올 음료, 껌, 차 및 비타민 복합제 등이 있다. In addition, the present invention provides a health functional food for the prevention or improvement of alcoholic liver disease, which contains a composition comprising a food additive that is food-acceptable. The health functional food of the present invention includes tablets, capsules, pills or liquids, etc. As foods to which the composition of the present invention can be added, for example, various drinks, meat, sausage, bread, candy, There are snacks, noodles, ice cream, dairy products, soups, drinks, alcoholic beverages, chewing gum, tea and vitamin complexes.

본 발명은 갈색거저리 유충 효소처리물, 흰점박이꽃무지 유충 효소처리물, 귀뚜라미 성충 효소처리물, 늙은호박 추출물, 계피추출물, 진피 추출물, 황기 추출물, 발아서리태 추출물, 마카 추출물, 인삼화뢰 추출물, 포도 추출물 및 황금추출물을 함유하는 조성물에 관한 것으로서, 알코올 분해효소의 활성 증가로 인한 숙취해소가 뛰어나고 알코올로 유도된 간독성 등이 완화되어 알코올성 간염, 알코올성 지방간과 같은 간 손상과 관련된 각종 질환의 치료용 조성물 또는 이들 질환의 예방과 개선을 위한 건강기능식품으로서 용이하게 이용될 수 있다.The present invention is a brown larva larvae enzymatic treatment, white spotted flower radish larvae enzymatic treatment, cricket adult enzymatic treatment, old pumpkin extract, cinnamon extract, dermis extract, astragalus extract, germinated frost extract, maca extract, ginseng lightning extract, grapes It relates to a composition containing an extract and a golden extract, excellent in resolving hangover due to increased activity of alcohol-degrading enzymes, and hepatic toxicity induced by alcohol is alleviated to treat various diseases related to liver damage such as alcoholic hepatitis and alcoholic fatty liver. Or it can be easily used as a health functional food for the prevention and improvement of these diseases.

이하 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 그러나, 본 발명을 여기서 설명되는 실시예에 한정되지 않고 다른 형태로 구체화 될 수 있다. 오히려, 여기서 소개되는 내용이 철저하고 완전해지도록, 당 업계자에게 본 발명의 사상을 충분히 전달하기 위해 제공하는 것이다.Hereinafter, a preferred embodiment of the present invention will be described in detail. However, the present invention is not limited to the embodiments described herein and may be embodied in other forms. Rather, it is provided to sufficiently convey the spirit of the present invention to those skilled in the art so that the contents introduced herein are thorough and complete.

제조예 1. 효소처리물과 생약 추출물의 제조와 첨가제의 준비Preparation Example 1. Preparation of enzyme treatment products and herbal extracts and preparation of additives

제조예 1-1. 갈색거저리 유충의 효소처리물, 흰점박이 꽃무지 유충의 효소처리물 및 쌍별귀뚜라미의 효소처리물의 준비Production Example 1-1. Preparation of enzyme treatment of brown larva larvae, enzyme treatment of white spotted flower larvae, and enzyme treatment of double-headed cricket

숙취해소용 조성물 제조를 위해, 갈색거저리 유충의 효소처리물, 흰점박이 꽃무지 유충의 효소처리물 및 쌍별귀뚜라미의 효소처리물을 제조하였다. In order to prepare a composition for relieving hangover, an enzyme treatment product of a brown larva larvae, an enzyme treatment product of a white spotted flower larvae, and an enzyme treatment product of a paired cricket were prepared.

전문 사육농가에서 8령의 갈색거저리 유충, 35일간 사육시킨 흰점박이꽃무지 유충 및 크기 2.5~3.0cm의 쌍별귀뚜라미 성충을 각각 구입하여, 갈색거저리 유충의 경우는 3일간 금식, 흰점박이꽃무지 유충은 3일간 금식시켜 배설물을 1차 배출시킨 다음 찹쌀가루를 7일간 식이하면서 사육시킨 후 다시 2일간 금식, 및 쌍별귀뚜라미는 1일간 금식시켜 배설물을 완전히 배출시킨 생것 상태에서 흐르는 물로 3회 수세하였다.Eight brown larvae larvae, white spotted larvae larvae raised for 35 days, and double-headed cricket adults of 2.5~3.0cm in size, respectively, were purchased from specialized breeding farms. For brown larvae, fasting for three days, white spotted larvae larvae Silver was fasted for 3 days to discharge the feces first, and then glutinous rice flour was fed for 7 days, then fasted for 2 days, and Ssangbye cricket was fasted for 1 day, and washed three times with running water in a state where the feces were completely discharged.

이 후. 갈색거저리 유충, 흰점박이 꽃무지 유충 및 쌍별귀뚜라미 성충을 각각 증숙기에 넣은 다음 3배 중량의 정제수를 첨가하여 압력 1.5kgf/cm2 온도 121℃의 가압고온 조건에서 90분간 가열시킨 다음, 물이 포함된 그 상태로 습식분쇄기(LSI, NEYZSCH, Srlb Bavaria, Germany)를 이용하여 bead size 0.4 mm, rotor speed 3,000 rpm의 조건으로 분쇄하여 갈색거저리 유충, 흰점박이꽃무지 유충 및 쌍별귀뚜라미 성충에 대해 분쇄물을 제조한다. 이 후 각 분쇄물 100 g당 Alcalase(Subtilisin Carlsberg, Novozymes)를 1g 첨가하여 40℃에서 5시간 동안 가수분해하는 과정을 수행하였다. 이렇게 가수분해된 각각의 분해물을 여과하여 60℃의 조건에서 감압농축기로 60 brix가 되도록 농축하여 갈색거저리 유충 효소처리물, 흰점박이 꽃무지 유충 효소처리물 및 쌍별귀뚜라미 효소처리물 수득하였다.after. After putting brown larvae, white-spotted flower larvae, and double-headed cricket larvae into the steamer, respectively, and adding 3 times the weight of purified water to add a pressure of 1.5 kgf/cm 2 and The mixture was heated for 90 minutes at a pressurized high temperature condition of 121°C, and then pulverized under conditions of bead size 0.4 mm and rotor speed 3,000 rpm using a wet grinder (LSI, NEYZSCH, Srlb Bavaria, Germany) in the state containing water. Grinding products are prepared for brown larvae, white spotted larvae larvae, and double-starred cricket adults. Thereafter, 1 g of Alcalase (Subtilisin Carlsberg, Novozymes) per 100 g of each pulverized product was added to perform hydrolysis at 40° C. for 5 hours. Each hydrolyzed product was filtered and concentrated to 60 brix under a reduced pressure concentrator under conditions of 60° C. to obtain a brown larva larvae enzyme treatment, a white spotted flower larvae enzyme treatment, and a paired cricket enzyme treatment.

제조예 1-2. 늙은호박 추출물, 계피추출물, 진피 추출물, 황기 추출물, 발아서리태 추출물, 마카 추출물, 인삼화뢰 추출물, 포도 추출물 및 황금추출물의 준비Preparation Example 1-2. Preparation of old pumpkin extract, cinnamon extract, dermis extract, astragalus extract, germinated frost extract, maca extract, ginseng torpedo extract, grape extract and golden extract

숙취해소용 조성물 제조를 위한 생약 추출물은 늙은호박, 계피, 진피, 황기, 발아서리태, 인삼화뢰, 포도 및 황금을 추출원료로 하여 제조하였다. 이때 서리태는 물에 불린 후 싹이 1~2cm 난 것을 사용하였다. The herbal extracts for the composition for the hangover relief were prepared by using old pumpkin, cinnamon, dermis, astragalus, germinated frost, ginseng torpedo, grapes and gold as the extraction raw materials. At this time, Seotae used to have 1~2cm buds after soaking in water.

이를 위해 상기 각각 추출원료에 8배 중량의 75(v/v)% 에탄올 수용액 또는 물을 넣고 80℃에서 12시간 추출 후 여과하여 액상만을 얻었다. 수거된 액상을 온도조절이 가능한 이중자켓에 넣은 다음 70℃에서 10시간 동안 교반하는 숙성과정을 거친 후, 60℃의 감압농축기를 이용하여 60 brix가 되도록 농축하여 각각의 추출물을 수득하였다. 이 때, 늙은호박, 진피는 75(v/v)% 에탄올 수용액을 용매로 하고, 나머지는 물을 용매로 하여 제조하였다. To this end, each of the extracted raw materials was added with an aqueous solution of 75 (v/v)% ethanol or water of 8 times the weight, extracted at 80° C. for 12 hours and filtered to obtain only a liquid phase. After the collected liquid was put into a double jacket with temperature control, and then aged for 10 hours at 70°C, the mixture was concentrated to 60 brix using a reduced pressure concentrator at 60°C to obtain each extract. At this time, the old pumpkin and the dermis were prepared by using 75(v/v)% ethanol aqueous solution as a solvent and the rest as water as a solvent.

이 외, 마카 추출물은 75(v/v)% 에탄올 수용액으로 추출한 칠레산 65 brix의 마카 농축물을 구입하여 준비하였다. In addition, maca extract was prepared by purchasing a maca concentrate of 65 brix from Chile extracted with an aqueous 75(v/v)% ethanol solution.

제조예 1-3. 첨가제의 준비Preparation Example 1-3. Preparation of additives

숙취해소용 조성물 제조를 위한 추가 첨가제로서 헛개열매 추출물, 울금 추출물, 갈근 추출물, 엉겅퀴 추출물, 포공영 추출물, 쑥 추출물, 사과 추출물, 감초 추출물, 대추 추출물, 아스파라긴산, 액상과당, 무수구연산, 비타민 C, 타우린, 젖산칼슘, L-아르기닌, 구연산삼나트륨, 니코틴산아미드, 효소처리스테비아, 비타민 B1 염산염, 비타민 B2 및 DL-알파-토코페릴초산염을 준비하였다. 이 때 각 추출물은 제조예 1-2의 방법으로 제조하되, 헛개열매, 울금, 갈근, 엉겅퀴, 포공영, 쑥의 추출물은 75(v/v)% 에탄올 수용액을 용매로 하여 제조하였고, 사과, 감초, 대추의 추출물은 물을 용매로 하여 제조하였다. 효소처리스테비아(스테비아추출물)는 통상적으로 이용되는 설탕 대체 감미료로서 ㈜대평에서 구입하여 사용하였다. As an additional additive for the production of a composition for relieving hangovers, buckthorn fruit extract, turmeric extract, brown root extract, thistle extract, pogongyoung extract, mugwort extract, apple extract, licorice extract, jujube extract, aspartic acid, liquid fructose, citric anhydride, vitamin C, taurine , Calcium lactate, L-arginine, trisodium citrate, nicotinamide, enzymatic treatment stevia, vitamin B1 hydrochloride, vitamin B2 and DL-alpha-tocopheryl acetate were prepared. At this time, each extract was prepared by the method of Preparation Example 1-2, but extracts of buckthorn, turmeric, brown root, thistle, pogongyoung, and wormwood were prepared using 75(v/v)% ethanol aqueous solution as a solvent, apple, licorice , The extract of jujube was prepared using water as a solvent. Enzyme-treated stevia (stevia extract) is a sugar substitute sweetener that is commonly used and was purchased from Daepyeong Co., Ltd. and used.

<실시예/비교예. 숙취해소용 조성물의 제조><Example/Comparative Example. Preparation of hangover-relieving composition>

다음의 숙취해소용 조성물을 제조예 1에서 준비된 시료를 혼합하여 제조하였다. The following hangover relief composition was prepared by mixing the sample prepared in Preparation Example 1.

실시예 1 내지 3Examples 1-3

각 시료를 하기 표 1의 조건으로 혼합하고, 물을 추가하여 총 중량이 3t인 음료 조성물을 제조하였다. Each sample was mixed under the conditions of Table 1 below, and water was added to prepare a beverage composition having a total weight of 3 t.

시료  sample 실시예 1Example 1 실시예 2Example 2 실시예 3Example 3 실시예 4Example 4 갈색거저리 유충 효소처리물 (g)Enzyme treatment of brown larvae (g) 100100 100100 100100 100100 흰점박이꽃무지 유충 효소처리물 (g)White Spotted Flower Plain Larva Enzyme Treatment (g) 2020 3030 4040 3030 쌍별귀뚜라미 성충 효소처리물 (g)Twin-Star Cricket Enzyme Treatment (g) 4040 3030 2020 3030 늙은호박 추출물 (g)Old Pumpkin Extract (g) 8080 8080 5050 6565 계피 추출물 (g)Cinnamon extract (g) 110110 3030 8080 7070 진피 추출물 (g)Dermis extract (g) 100100 7070 150150 110110 황기 추출물 (g)Astragalus extract (g) 3030 100100 100100 6565 발아서리태 추출물 (g)Germinated frost extract (g) 150150 140140 120120 135135 마카 추출물 (g)Maca extract (g) 8080 4040 9090 6565 인삼화뢰 추출물 (g)Ginseng torpedo extract (g) 100100 150150 100100 125125 포도 추출물 (g)Grape extract (g) 7070 100100 3030 6565 황금 추출물 (g)Golden extract (g) 4040 5050 4040 2626

실시예 5Example 5

실시예 1의 성분에 아래 조건으로 헛개열매 추출물 등의 첨가제를 혼합하고 물을 추가하여 총 3t의 중량이 되도록 음료 조성물을 제조하였다. The composition of Example 1 was mixed with additives such as buckthorn extract under the following conditions, and water was added to prepare a beverage composition to have a total weight of 3 tons.

실시예 1의 성분 : 갈색거저리 유충 효소처리물 100 g, 흰점박이꽃무지 유충 효소처리물 20 g, 쌍별귀뚜라미 성충 효소처리물 40 g, 늙은호박 추출물 80 g, 계피 추출물 110 g, 진피 추출물 100 g, 황기 추출물 30 g, 발아서리태 추출물 150 g, 마카 추출물 80 g, 인삼화뢰 추출물 100 g, 포도 추출물 70 g, 황금 추출물 40 g Ingredients of Example 1: brown larva larvae enzymatic treatment 100 g, white spotted flower larvae larvae enzymatic treatment 20 g, double-headed cricket adult enzymatic treatment 40 g, old pumpkin extract 80 g, cinnamon extract 110 g, dermis extract 100 g , Hwanggi extract 30 g, germinated frost extract 150 g, maca extract 80 g, ginseng torpedo extract 100 g, grape extract 70 g, golden extract 40 g

추가 성분 : 헛개열매 추출물 325 g, 울금 추출물 75 g, 갈근 추출물 75 g, 엉겅퀴 추출물 75 g, 포공영 추출물 75 g, 쑥 추출물 75 g, 사과 추출물 250 g, 감초 추출물 12 g, 대추 추출물 12 g, 아스파라긴산 75 g, 액상과당 3500 g, 무수구연산 150 g, 비타민C 50 g, 타우린 35 g, 젖산칼슘 30 g, L-아르기닌 25 g, 구연산삼나트륨 12 g, 니코틴산아미드 12 g, 효소처리스테비아 3 g, 비타민B1염산염 2 g, 비타민B2 2 g, DL-알파-토코페릴초산염 2 gAdditional Ingredients: 325 g of buckthorn extract, 75 g of turmeric extract, 75 g of extract of thistle root, 75 g of thistle extract, 75 g of pogongyoung extract, 75 g of mugwort extract, 250 g of apple extract, 12 g of licorice extract, 12 g of jujube extract, 12 g of aspartic acid 75 g, liquid fructose 3500 g, citric anhydride 150 g, vitamin C 50 g, taurine 35 g, calcium lactate 30 g, L-arginine 25 g, trisodium citrate 12 g, nicotinic acid amide 12 g, enzyme-treated stevia 3 g, 2 g of vitamin B1 hydrochloride, 2 g of vitamin B2, 2 g of DL-alpha-tocopheryl acetate

실시예 6Example 6

실시예 4의 성분에 아래 조건으로 헛개열매 추출물 등의 첨가제를 혼합하고 물을 추가하여 총 3t의 중량이 되도록 음료 조성물을 제조하였다. The composition of Example 4 was mixed with additives such as buckthorn extract under the following conditions, and water was added to prepare a beverage composition to have a total weight of 3 tons.

실시예 4의 성분 : 갈색거저리 유충 효소처리물 100 g, 흰점박이꽃무지 유충 효소처리물 30 g, 쌍별귀뚜라미 성충 효소처리물 30 g, 늙은호박 추출물 65 g, 계피 추출물 70 g, 진피 추출물 110 g, 황기 추출물 65 g, 발아서리태 추출물 135 g, 마카 추출물 65 g, 인삼화뢰 추출물 125 g, 포도 추출물 65 g, 황금 추출물 26 g Ingredients of Example 4: brown larva larvae enzyme treatment 100 g, white spotted flower larvae larvae enzyme treatment 30 g, double-headed cricket adult enzyme treatment 30 g, old pumpkin extract 65 g, cinnamon extract 70 g, dermis extract 110 g , Hwanggi extract 65 g, germinated frost extract 135 g, maca extract 65 g, ginseng torpedo extract 125 g, grape extract 65 g, golden extract 26 g

추가 성분 : 헛개열매 추출물 325 g, 울금 추출물 75 g, 갈근 추출물 75 g, 엉겅퀴 추출물 75 g, 포공영 추출물 75 g, 쑥 추출물 75 g, 사과 추출물 250 g, 감초 추출물 12 g, 대추 추출물 12 g, 아스파라긴산 75 g, 액상과당 3500 g, 무수구연산 150 g, 비타민C 50 g, 타우린 35 g, 젖산칼슘 30 g, L-아르기닌 25 g, 구연산삼나트륨 12 g, 니코틴산아미드 12 g, 효소처리스테비아 3 g, 비타민B1염산염 2 g, 비타민B2 2 g, DL-알파-토코페릴초산염 2 gAdditional Ingredients: 325 g of buckthorn extract, 75 g of turmeric extract, 75 g of extract of thistle root, 75 g of thistle extract, 75 g of pogongyoung extract, 75 g of mugwort extract, 250 g of apple extract, 12 g of licorice extract, 12 g of jujube extract, 12 g of aspartic acid 75 g, liquid fructose 3500 g, citric anhydride 150 g, vitamin C 50 g, taurine 35 g, calcium lactate 30 g, L-arginine 25 g, trisodium citrate 12 g, nicotinic acid amide 12 g, enzyme-treated stevia 3 g, 2 g of vitamin B1 hydrochloride, 2 g of vitamin B2, 2 g of DL-alpha-tocopheryl acetate

비교예 1 내지 3Comparative Examples 1 to 3

각 시료를 하기 표 2의 조건으로 혼합하고, 물을 추가하여 총 중량이 3t인 음료 조성물을 제조하였다. Each sample was mixed under the conditions of Table 2 below, and water was added to prepare a beverage composition having a total weight of 3 t.

시료  sample 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 갈색거저리 유충 효소처리물 (g)Enzyme treatment of brown larvae (g) 400400 00 100100 흰점박이꽃무지 유충 효소처리물 (g)White Spotted Flower Plain Larva Enzyme Treatment (g) 300300 00 150150 쌍별귀뚜라미 성충 효소처리물 (g)Twin-Star Cricket Enzyme Treatment (g) 220220 00 6969 늙은호박 추출물 (g)Old Pumpkin Extract (g) 00 7070 100100 계피 추출물 (g)Cinnamon extract (g) 00 110110 1010 진피 추출물 (g)Dermis extract (g) 00 150150 3030 황기 추출물 (g)Astragalus extract (g) 00 100100 210210 발아서리태 추출물 (g)Germinated frost extract (g) 00 120120 4040 마카 추출물 (g)Maca extract (g) 00 9090 2020 인삼화뢰 추출물 (g)Ginseng torpedo extract (g) 00 150150 180180 포도 추출물 (g)Grape extract (g) 00 7070 1010 황금 추출물 (g)Golden extract (g) 00 6060 1One

비교예 4Comparative Example 4

대한민국 등록특허 제10-1919839호의 실시예 2-1의 조성물을 총 920g 준비하고, 물을 추가하여 총 3t이 되게 하였다. A total of 920 g of the composition of Example 2-1 of Korean Patent Registration No. 10-1919839 was prepared, and water was added to make a total of 3 tons.

비교예 5 Comparative Example 5

대한민국 등록특허 제10-1852840호의 실시예 2-1의 조성물을 920g 준비하고 물을 추가하여 총 3t이 되게 하였다. Prepare the composition of Example 2-1 of Republic of Korea Patent No. 10-1852840 No. 920g and added water to make a total of 3t.

비교예 6 Comparative Example 6

비교예 3의 성분에 아래 조건으로 헛개열매 추출물 등의 첨가제를 혼합하고 물을 첨가하여 총 3t의 중량이 되도록 음료 조성물을 제조하였다. To the components of Comparative Example 3 was mixed with additives such as buckthorn extract under the following conditions and water was added to prepare a beverage composition to have a total weight of 3 tons.

비교예 3의 성분 : 갈색거저리 유충 효소처리물 100 g, 흰점박이꽃무지 유충 효소처리물 150 g, 쌍별귀뚜라미 성충 효소처리물 69 g, 늙은호박 추출물 100 g, 계피 추출물 10 g, 진피 추출물 30 g, 황기 추출물 210 g, 발아서리태 추출물 40 g, 마카 추출물 20 g, 인삼화뢰 추출물 180 g, 포도 추출물 10 g, 황금 추출물 1 g Components of Comparative Example 3: brown larva larvae enzymatic treatment 100 g, white spotted flower larvae larvae enzymatic treatment 150 g, double-starred cricket adult enzyme treatment 69 g, old pumpkin extract 100 g, cinnamon extract 10 g, dermis extract 30 g , Hwanggi extract 210 g, germinated frost extract 40 g, maca extract 20 g, ginseng torpedo extract 180 g, grape extract 10 g, golden extract 1 g

추가 성분 : 헛개열매 추출물 325 g, 울금 추출물 75 g, 갈근 추출물 75 g, 엉겅퀴 추출물 75 g, 포공영 추출물 75 g, 쑥 추출물 75 g, 사과 추출물 250 g, 감초 추출물 12 g, 대추 추출물 12 g, 아스파라긴산 75 g, 액상과당 3500 g, 무수구연산 150 g, 비타민C 50 g, 타우린 35 g, 젖산칼슘 30 g, L-아르기닌 25 g, 구연산삼나트륨 12 g, 니코틴산아미드 12 g, 효소처리스테비아 3 g, 비타민B1염산염 2 g, 비타민B2 2 g, DL-알파-토코페릴초산염 2 gAdditional Ingredients: 325 g of buckthorn extract, 75 g of turmeric extract, 75 g of extract of thistle root, 75 g of thistle extract, 75 g of pogongyoung extract, 75 g of mugwort extract, 250 g of apple extract, 12 g of licorice extract, 12 g of jujube extract, 12 g of aspartic acid 75 g, liquid fructose 3500 g, citric anhydride 150 g, vitamin C 50 g, taurine 35 g, calcium lactate 30 g, L-arginine 25 g, trisodium citrate 12 g, nicotinic acid amide 12 g, enzyme-treated stevia 3 g, 2 g of vitamin B1 hydrochloride, 2 g of vitamin B2, 2 g of DL-alpha-tocopheryl acetate

실험예 1. 음료 조성물의 관능검사Experimental Example 1. Sensory test of beverage composition

실시예 5, 실시예 6 및 비교예 6의 음료 조성물에 대해 관능평가를 실시하였다. 상기 관능평가는 10명의 전문가와 무작위로 선별된 20명의 비전문가가 참여하였다.The sensory evaluation was performed on the beverage compositions of Example 5, Example 6 and Comparative Example 6. The sensory evaluation involved 10 experts and 20 randomly selected non-professionals.

평가방법에 사용된 기호도 검사 방법은 7점 척도법으로, 1점 대단히 싫다. 2점 싫다. 3점 약간 싫다. 4점 보통이다. 5점 약간 좋다. 6점 좋다. 7점 대단히 좋다로 구분하여 진행하였다. 그 결과는 표 3에서와 같이 실시예 5 및 실시예 6의 음료 조성물이 비교예 6의 음료 조성물에 비해 색깔, 맛, 이취 및 기호도 모두 증가된 것으로 나타났다.The preference test used in the evaluation method is a 7-point scale method, and I hate it for 1 point. I hate 2 points. I hate 3 points. 4 points is normal. Five points is good. 6 is good. We proceeded by classifying with 7 points very good. As a result, as shown in Table 3, the beverage compositions of Example 5 and Example 6 showed that the color, taste, odor, and taste were all increased compared to the beverage composition of Comparative Example 6.

구 분division color flavor 이취없음No odor 기호도Preference 실시예 5Example 5 6.46.4 6.06.0 6.56.5 5.95.9 실시예 6Example 6 5.85.8 5.95.9 6.26.2 6.06.0 비교예 6Comparative Example 6 4.34.3 4.14.1 3.93.9 4.24.2

실험예 2. 알코올 분해효소의 활성 확인 Experimental Example 2. Confirmation of the activity of alcohol degrading enzyme

알코올 분해효소인 알데히드탈수소효소(ALDH) 및 아세트알데히드(ADH)의 활성을 측정하였다. The activity of alcohol degrading enzymes, aldehyde dehydrogenase (ALDH) and acetaldehyde (ADH), was measured.

이를 위해 음료로 제조하기 위해 물을 첨가하기 전의 실시예 1 내지 4 및 비교예 1 내지 5의 각 조성물을 각 성분이 골고루 혼합되도록 DMSO(dimethyl sulfoxide)에 희석하여 100㎎/㎖의 농도로 준비하고 이를 사용하여 각 실험을 수행하였다. To this end, each composition of Examples 1 to 4 and Comparative Examples 1 to 5 before adding water to prepare a beverage was diluted in dimethyl sulfoxide (DMSO) so that each component was evenly mixed and prepared at a concentration of 100 mg/ml. Each experiment was performed using this.

ALDH의 활성 측정은 Aldehyde dehydrogenase activity colorimetric assay kit (BioVision, catalog #K731-100)를 사용하여 BioVision protocol에 의거하여 측정하였다. 이때 시료를 첨가하지 않은 것을 대조군으로 하였으며, 시료의 ALDH의 활성은 대조군에 대한 상대활성(%)으로 나타내었다. 3회 측정하여 평균값을 구한 후 하기 표 4에 나타내었다. The activity of ALDH was measured using the Aldehyde dehydrogenase activity colorimetric assay kit (BioVision, catalog #K731-100) according to the BioVision protocol. At this time, the sample was not added as a control, and the ALDH activity of the sample was expressed as a relative activity (%) relative to the control. After measuring three times to obtain the average value, it is shown in Table 4 below.

ADH 활성 측정은 Alcohol dehydrogenase activity colorimetric assay kit (BioVision, catalog #K787-100)를 사용하여 BioVision protocol에 의거하여 측정하였다. 이때 시료를 첨가하지 않은 것을 대조군으로 하였으며, 시료의 ADH의 활성은 대조군에 대한 상대활성(%)으로 나타내어 하기의 표 4에 나타내었다. ADH activity was measured according to the BioVision protocol using an alcohol dehydrogenase activity colorimetric assay kit (BioVision, catalog #K787-100). At this time, the sample was not added as a control, and the ADH activity of the sample was expressed in relative activity (%) relative to the control, and is shown in Table 4 below.

구분division ALDH 활성(%)ALDH activity (%) ADL 활성(%)ADL activity (%) 대조군Control 100100 100100 실시예 1 Example 1 176176 350350 실시예 2Example 2 165165 363363 실시예 3Example 3 158158 312312 실시예 4Example 4 161161 314314 비교예 1Comparative Example 1 115115 152152 비교예 2Comparative Example 2 107107 179179 비교예 3Comparative Example 3 117117 162162 비교예 4Comparative Example 4 132132 215215 비교예 5Comparative Example 5 122122 256256

실험예 3. 혼합물의 간 세포보호 활성 확인(in vitro)Experimental Example 3. Confirmation of the liver cell protective activity of the mixture (in vitro)

실험예 2에서 준비한 실시예 1 내지 4 및 비교예 1 내지 5의 DMSO 희석액을 에탄올 처리된 HepG2(human liver cancer cell line)에 처리하여 알코올로 손상된 간세포의 보호활성을 확인하였다. Prepared in Experimental Example 2 The DMSO dilutions of Examples 1 to 4 and Comparative Examples 1 to 5 were treated with ethanol-treated human liver cancer cell line (HepG2) to confirm the protective activity of liver cells damaged by alcohol.

이 때, HepG2는 하기의 방법으로 배양한 것을 사용하였다. 구체적으로 배양액으로는 10% FBS(fetal bovine serum) 및 100 IU/mL 페니실린이 첨가된 DMEM(Dulbecco's modified Eagle's medium, Giboc, USA)배지를 사용하여 37℃, 5% CO2 조건의 인큐베이터에서 배양하였고, 3~4일에 한 번씩 계대 유지하였다.At this time, HepG2 was cultured in the following manner. Specifically, 10% FBS (fetal bovine serum) and 100 IU/mL penicillin-added DMEM (Dulbecco's modified Eagle's medium, Giboc, USA) medium were used as a culture medium and cultured in an incubator at 37°C and 5% CO 2 conditions. , Passed once every 3-4 days.

실험을 위해, HepG2를 7x103/well 농도로 플레이트(plate)에 24시간 배양하고, 각 희석 시료를 최종농도 100 ㎍/㎖이 되도록 처리하였다. 이 후 1시간 뒤에 95% 에탄올을 각 시료가 처리된 배지 내에 200 mM이 되도록 첨가한 후 17시간 동안 배양하였다. 3일간 같은 조건으로 매일 배지를 교체하고 각 시료와 에탄올을 방법으로 처리하여 세포손상을 유도하였다. 그런 다음, MTT assay 방법을 이용하여 485 nm에서 흡광도를 측정하여 세포생존율을 조사하였다. 세포 생존율은 무처리(대조군)의 생존도 100%를 기준으로 시험군의 상대적인 생존율을 계산하였다. For the experiment, HepG2 was incubated in a plate at a concentration of 7x10 3 /well for 24 hours, and each diluted sample was treated to a final concentration of 100 µg/ml. After 1 hour, 95% ethanol was added so that each sample was 200 mM in the treated medium, and then cultured for 17 hours. Cells were induced by replacing the medium every day under the same conditions for 3 days and treating each sample and ethanol by the method. Then, the cell viability was investigated by measuring absorbance at 485 nm using the MTT assay method. The cell viability was calculated based on 100% of the untreated (control) survival rate.

구분division 세포생존율 활성(%)Cell viability (%) 대조군Control 100.2100.2 에탄올ethanol 25.225.2 에탄올 + 실시예 1 Ethanol + Example 1 96.496.4 에탄올 + 실시예 2Ethanol + Example 2 95.295.2 에탄올 + 실시예 3Ethanol + Example 3 98.298.2 에탄올 + 실시예 4Ethanol + Example 4 97.597.5 에탄올 + 비교예 1Ethanol + Comparative Example 1 48.248.2 에탄올 + 비교예 2Ethanol + Comparative Example 2 45.245.2 에탄올 + 비교예 3Ethanol + Comparative Example 3 48.248.2 에탄올 + 비교예 4Ethanol + Comparative Example 4 67.567.5 에탄올 + 비교예 5Ethanol + Comparative Example 5 69.269.2

그 결과, 상기 표 5와 같이 실시예 1 내지 4의 희석시료 처리군이 비교예 1 내지 5의 희석시료 처리군과 비교하여 HepG2의 생존율이 현저하게 높은 것을 확인할 수 있고 알코올 처리로 인한 대부분의 손상을 회복하는 것을 알 수 있다. As a result, as shown in Table 5, it can be confirmed that the survival rate of HepG2 was significantly higher in the diluted sample treatment groups of Examples 1 to 4 compared to the diluted sample treatment groups of Comparative Examples 1 to 5, and most of the damages caused by alcohol treatment It can be seen to recover.

실험예 4. 숙취해소 평가Experimental Example 4. Evaluation of hangover cancellation

실시예 5, 실시예 6 및 비교예 6의 음료 조성물에 대한 숙취해소 효과를 평가하였다. The effect of releasing hangover on the beverage compositions of Examples 5, 6 and 6 was evaluated.

이때, 숙취해소 음료로 판매되는 다음의 제품 2종도 사용하였다. At this time, the following two products sold as hangover-relieving beverages were also used.

#1 : 쌀배아 발효추출물, 타우린, 헛개나무열매추출물, 생강, 효모추출물, 자라 추출물, 황기 추출물, 무수구연산, DL-사과산, D-알라닌, 니코틴산아미드, 구연산삼나트륨, 복합허브추출물, 합성향료, 과당, 설탕#1: Rice embryo fermentation extract, taurine, hut fruit extract, ginger, yeast extract, Zara extract, astragalus extract, citric anhydride, DL-apple acid, D-alanine, nicotinic acid amide, trisodium citrate, complex herbal extract, synthetic flavor , Fructose, sugar

#2 : 황칠나무 추출물, 사과 추출물, 타우린, 모과 추출물, 구연산, 비타민C, 황금복합추출물, 효소처리스테비아, L-아스파라긴, 과당, 프락토올리고당, 사양벌꿀#2: Hwangchil tree extract, apple extract, taurine, quince extract, citric acid, vitamin C, golden complex extract, enzymatic treatment stevia, L-asparagine, fructose, fructooligosaccharide, honey

평가방법은 하기와 같다. 실험 대상자는 평소 주량이 소주 1병(360ml)을 일주일에 2 내지 3회 정도 음용하는 성인 남녀들이며, 이들을 무작위로 10명씩 각 처리군으로 모아 평가하게 하였다. The evaluation method is as follows. The test subjects were adult men and women who drink 1 bottle of soju (360 ml) 2 to 3 times a week, and were randomly evaluated by collecting 10 of them into each treatment group.

음주방법은 알코올 함량이 19%(v/v)인 소주 한잔에 안주로 삼겹살 1점을 같이 섭취하게 하고, 1인당 1.5병(360ml)을 30분 동안에 마시게 하였으며, 음주 후 3시간 후에 발열, 갈증, 취기, 두통 등에 대한 억제 효과를 5점 평가방법으로 평가하였다. The drinking method was to drink 1 point of pork belly as a snack in a glass of soju with an alcohol content of 19% (v/v), drink 1.5 bottles (360 ml) per person for 30 minutes, and fever after 3 hours after drinking. The inhibitory effect on thirst, odor, and headache was evaluated by a 5-point evaluation method.

5 : 매우 좋음 <-> 1 : 매우 나쁨5: Very good <-> 1: Very bad

평가 결과 표 6에서와 같이 본 발명의 음료 조성물이 발열, 갈증, 취기, 두통, 매스꺼움 및 구토 등을 억제하는 효과가 우수한 것으로 평가되었다.As a result of the evaluation, as shown in Table 6, the beverage composition of the present invention was evaluated as having an excellent effect of suppressing fever, thirst, odor, headache, nausea, and vomiting.

구분division 발열 억제Fever suppression 갈증 억제Suppress thirst 취기 억제Suppression 두통 억제Headache suppression 매스꺼움 억제Suppressing nausea 구토 억제Suppressing vomiting 실시예 5Example 5 4.34.3 4.44.4 4.34.3 4.64.6 4.14.1 4.24.2 실시예 6Example 6 4.54.5 4.24.2 4.54.5 4.24.2 4.24.2 3.93.9   비교예 6Comparative Example 6 3.13.1 3.13.1 3.23.2 3.43.4 3.33.3 3.23.2   #1#One 2.82.8 3.23.2 3.33.3 2.72.7 3.53.5 2.92.9 #2#2 3.63.6 2.92.9 3.63.6 2.72.7 3.23.2 2.82.8

Claims (4)

갈색거저리 유충 효소처리물 100 중량부 기준으로, 흰점박이꽃무지 유충 효소처리물 20~40 중량부, 귀뚜라미 성충 효소처리물 20~40 중량부, 늙은호박 추출물 50~80 중량부, 계피 추출물 30~110 중량부, 진피 추출물 70~150 중량부, 황기 추출물 30~100 중량부, 발아서리태 추출물 120~150 중량부, 마카 추출물 40~90 중량부, 인삼화뢰 추출물 100~150 중량부, 포도 추출물 30~100 중량부 및 황금 추출물 2~50 중량부를 함유하는 것을 특징으로 하는 숙취해소 또는 간보호용 건강기능 식품. Based on 100 parts by weight of the brown larva larvae enzyme treatment, 20 to 40 parts by weight of the white spotted flower larvae larvae enzyme treatment, 20 to 40 parts by weight of cricket adult enzyme treatment, 50 to 80 parts by weight of the old pumpkin extract, and 30 to cinnamon extract 110 parts by weight, dermis extract 70-150 parts by weight, astragalus extract 30-100 parts by weight, germinated frost extract 120-150 parts by weight, maca extract 40-90 parts by weight, ginseng hoehwa extract 100-150 parts by weight, grape extract 30- Health functional food for hangover relief or liver protection, characterized by containing 100 parts by weight and 2 to 50 parts by weight of golden extract. 제1항에 있어서,
상기 식품에 헛개열매 추출물, 울금 추출물, 갈근 추출물, 엉겅퀴 추출물, 포공영 추출물, 쑥 추출물, 사과 추출물, 감초 추출물, 대추 추출물, 아스파라긴산, 액상과당, 무수구연산, 비타민 C, 타우린, 젖산칼슘, L-아르기닌, 구연산삼나트륨, 니코틴산아미드, 효소처리스테비아, 비타민 B1 염산염, 비타민 B2 및 DL-알파-토코페릴초산염이 추가되는 것을 특징으로 하는 숙취해소 또는 간보호용 건강기능 식품.
According to claim 1,
In the above foods, fruit extract, turmeric extract, root extract, thistle extract, pogongyoung extract, mugwort extract, apple extract, licorice extract, jujube extract, aspartic acid, liquid fructose, citric anhydride, vitamin C, taurine, calcium lactate, L-arginine , Trisodium citrate, nicotinic acid amide, enzymatic treatment stevia, vitamin B1 hydrochloride, vitamin B2 and DL-alpha-tocopheryl acetate are added to hangover or health functional food for liver protection.
갈색거저리 유충 효소처리물 100 중량부 기준으로, 흰점박이꽃무지 유충 효소처리물 20~40 중량부, 귀뚜라미 성충 효소처리물 20~40 중량부, 늙은호박 추출물 50~80 중량부, 계피 추출물 30~110 중량부, 진피 추출물 70~150 중량부, 황기 추출물 30~100 중량부, 발아서리태 추출물 120~150 중량부, 마카 추출물 40~90 중량부, 인삼화뢰 추출물 100~150 중량부, 포도 추출물 30~100 중량부 및 황금 추출물 2~50 중량부를 함유하는 조성물을 함유하거나,
상기 조성물에 헛개열매 추출물, 울금 추출물, 갈근 추출물, 엉겅퀴 추출물, 포공영 추출물, 쑥 추출물, 사과 추출물, 감초 추출물, 대추 추출물, 아스파라긴산, 액상과당, 무수구연산, 비타민 C, 타우린, 젖산칼슘, L-아르기닌, 구연산삼나트륨, 니코틴산아미드, 효소처리스테비아, 비타민 B1 염산염, 비타민 B2 및 DL-알파-토코페릴초산염이 추가되는 조성물을 함유하는 것을 특징으로 하는
알코올성 간질환의 예방 또는 치료용 약학 조성물.
Based on 100 parts by weight of the brown larva larvae enzyme treatment, 20 to 40 parts by weight of the white spotted flower larvae larvae enzyme treatment, 20 to 40 parts by weight of cricket adult enzyme treatment, 50 to 80 parts by weight of the old pumpkin extract, and 30 to cinnamon extract 110 parts by weight, dermis extract 70-150 parts by weight, astragalus extract 30-100 parts by weight, germinated frost extract 120-150 parts by weight, maca extract 40-90 parts by weight, ginseng hoehwa extract 100-150 parts by weight, grape extract 30- Contains a composition containing 100 parts by weight and 2 to 50 parts by weight of golden extract, or
In the above composition, fruit extract, turmeric extract, brown root extract, thistle extract, pogongyoung extract, mugwort extract, apple extract, licorice extract, jujube extract, aspartic acid, liquid fructose, citric anhydride, vitamin C, taurine, calcium lactate, L-arginine , Trisodium citrate, nicotinic acid amide, enzymatic treatment stevia, vitamin B1 hydrochloride, vitamin B2 and DL-alpha-tocopheryl acetate.
Pharmaceutical composition for the prevention or treatment of alcoholic liver disease.
제1항 또는 제2항의 식품을 함유하는 것을 특징으로 하는 알코올성 간질환의 예방 또는 개선용 건강기능 식품.A health functional food for the prevention or improvement of alcoholic liver disease, comprising the food of claim 1 or 2.
KR1020190152440A 2019-11-25 2019-11-25 Composition for hepatoprotective or ameliorating hangover containing herbal extract and edible insect enzyme-decomposed with enzyme KR102120323B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190152440A KR102120323B1 (en) 2019-11-25 2019-11-25 Composition for hepatoprotective or ameliorating hangover containing herbal extract and edible insect enzyme-decomposed with enzyme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190152440A KR102120323B1 (en) 2019-11-25 2019-11-25 Composition for hepatoprotective or ameliorating hangover containing herbal extract and edible insect enzyme-decomposed with enzyme

Publications (1)

Publication Number Publication Date
KR102120323B1 true KR102120323B1 (en) 2020-06-10

Family

ID=71087113

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190152440A KR102120323B1 (en) 2019-11-25 2019-11-25 Composition for hepatoprotective or ameliorating hangover containing herbal extract and edible insect enzyme-decomposed with enzyme

Country Status (1)

Country Link
KR (1) KR102120323B1 (en)

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020064151A (en) 2001-01-31 2002-08-07 (주)생명의나무 Lower alcohol insoluble extract and a polysaccharide therein isolated from hovenia dulcis var. koreana nakai having antihepatotoxic and anti-hangover activity and composition containing same
KR20020081995A (en) 2001-04-23 2002-10-30 (주)드리고 Compound foods curing Hepato-toxicity and hangover, their formulations, and manufacturing methods
KR100453575B1 (en) 2001-07-09 2004-10-20 대한민국 Food compositons derived from or containing crickets, exerting hepato-protective, antifatigue, enhancing activity of ethanol degradation, and inhibiting the formation of lipid-peroxidation
KR100477957B1 (en) 2001-04-13 2005-03-23 재단법인서울대학교산학협력재단 Novel pyrrole derivatives isolated from lycium chinense mill having hepatoprotective activity and composition containing same
KR100633851B1 (en) 2004-04-22 2006-10-16 학교법인 상지학원 Composition comprising the extract of heat-treated Allium victorialis L. var. platyphyllum for treating or preventing of liver disease or liver protection
KR101090284B1 (en) 2011-07-21 2011-12-07 김진 Tonic comprising red ginseng and deer antlers extracts and manufacturing method thereof
KR101106499B1 (en) 2009-03-24 2012-01-20 장흥군 Food composition with hepatoprotective effect containing the peduncle extracts of Hovenia dulcis Thunb
KR20140137289A (en) * 2013-05-22 2014-12-02 재단법인 한국한방산업진흥원 Composition comprising an extract of Alpinia officinarum Hance for preventing and treating hangover or liver disease
KR20150075838A (en) 2013-12-26 2015-07-06 권오성 A jujube jelly with heating matuerd jujube and method of manufacturing its
KR101852840B1 (en) 2018-01-02 2018-04-27 주식회사 한미양행 Hepatoprotective composition comprising enzyme treated larva
KR101881369B1 (en) 2017-02-21 2018-07-24 충남대학교산학협력단 Anti-oxidant Aged Chestnut Inner Shell and Anti-oxidant Composition Comprising the Aged Chentnut Inner Shell or Its Extract
KR101919839B1 (en) 2018-07-06 2018-11-19 주식회사 한미양행 Composition for hepatoprotective and ameliorating hangover containing cricket material enzyme-decomposed with Alcalase
KR101948661B1 (en) 2017-12-11 2019-02-18 주식회사 코리아나화장품 Cosmetic composition for skin whitening containing magnolia sieboldii extract ripened at low-temperature using bamboo charcoal

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020064151A (en) 2001-01-31 2002-08-07 (주)생명의나무 Lower alcohol insoluble extract and a polysaccharide therein isolated from hovenia dulcis var. koreana nakai having antihepatotoxic and anti-hangover activity and composition containing same
KR100477957B1 (en) 2001-04-13 2005-03-23 재단법인서울대학교산학협력재단 Novel pyrrole derivatives isolated from lycium chinense mill having hepatoprotective activity and composition containing same
KR20020081995A (en) 2001-04-23 2002-10-30 (주)드리고 Compound foods curing Hepato-toxicity and hangover, their formulations, and manufacturing methods
KR100453575B1 (en) 2001-07-09 2004-10-20 대한민국 Food compositons derived from or containing crickets, exerting hepato-protective, antifatigue, enhancing activity of ethanol degradation, and inhibiting the formation of lipid-peroxidation
KR100633851B1 (en) 2004-04-22 2006-10-16 학교법인 상지학원 Composition comprising the extract of heat-treated Allium victorialis L. var. platyphyllum for treating or preventing of liver disease or liver protection
KR101106499B1 (en) 2009-03-24 2012-01-20 장흥군 Food composition with hepatoprotective effect containing the peduncle extracts of Hovenia dulcis Thunb
KR101090284B1 (en) 2011-07-21 2011-12-07 김진 Tonic comprising red ginseng and deer antlers extracts and manufacturing method thereof
KR20140137289A (en) * 2013-05-22 2014-12-02 재단법인 한국한방산업진흥원 Composition comprising an extract of Alpinia officinarum Hance for preventing and treating hangover or liver disease
KR20150075838A (en) 2013-12-26 2015-07-06 권오성 A jujube jelly with heating matuerd jujube and method of manufacturing its
KR101881369B1 (en) 2017-02-21 2018-07-24 충남대학교산학협력단 Anti-oxidant Aged Chestnut Inner Shell and Anti-oxidant Composition Comprising the Aged Chentnut Inner Shell or Its Extract
KR101948661B1 (en) 2017-12-11 2019-02-18 주식회사 코리아나화장품 Cosmetic composition for skin whitening containing magnolia sieboldii extract ripened at low-temperature using bamboo charcoal
KR101852840B1 (en) 2018-01-02 2018-04-27 주식회사 한미양행 Hepatoprotective composition comprising enzyme treated larva
KR101919839B1 (en) 2018-07-06 2018-11-19 주식회사 한미양행 Composition for hepatoprotective and ameliorating hangover containing cricket material enzyme-decomposed with Alcalase

Similar Documents

Publication Publication Date Title
KR101483592B1 (en) Decreasing Effect in Blood Ethanol Concentration and Improvement of Hepatic Function Including Preparation of Sprouts Hordeum Vulgare Extracts
KR20160144791A (en) Composition for relieving menopausal symptom
KR101449804B1 (en) Antihypertensive composition comprising gelatin extract from skate skin and peptide isolated from the extract
WO2019038658A1 (en) A method for producing a polyphenolic composition from barley malt
KR101407150B1 (en) A composition and functional food comprising an extracts of Rosa rugosa preventing or treating a physical stress-involved disease
KR100883278B1 (en) A persimmon extract and the producing method thereof
KR102151011B1 (en) Composition for preventing, improving or treating liver disease comprising fermented liquor of aged sprout ginseng extract as effective component
KR102120323B1 (en) Composition for hepatoprotective or ameliorating hangover containing herbal extract and edible insect enzyme-decomposed with enzyme
KR101513240B1 (en) A composition comprising extracts of herbal mixture for fatigue recovery as in gradient compounds
KR20150088223A (en) Compositions for preventing or improving of alcoholic liver disease, or reducing alcoholic hangup comprising Rosa rugosa extracts
KR20230036758A (en) Mixed extraction of enzyme treatment ultrahigh pressure for sleep inducing and insomnia
KR102064516B1 (en) An antibacterial composition comprising an leaf and root extract of cudrania tricuspidata, and extract of licorice
KR20180075763A (en) Composition comprising the ethanol extract of Portulacea oleracea for preventing and treating of Alcoholic liver damage
KR101817053B1 (en) Composition for anti-oxidant or anti-cancer or anti-obesity or immune-enhancing containing Codonopsis lanceolata extract
KR101845704B1 (en) Composition comprising kynurenic acid for relieving hangover
KR20200081550A (en) Composition containing an fermented extract of protaetia brevitarsis seulensis as an active ingredient and manufacturing the same
KR20150106187A (en) Composition for antioxidation comprising the seed extract of cornus officinalis
KR100673594B1 (en) Extracts of soy hypocotyl and/or hull with inhibitory effects on carcinogenesis and composition comprising the same
KR20190084732A (en) A composition for improving, preventing and treating obesity comprising fermented pollack skin
KR102457306B1 (en) Health function food composition comprising lactobacillus for improving skin and vowel function and method of preparing the same
KR20130082249A (en) Composition for preventing or improving the metabolic syndrome containing parthenocissus tricuspidata extract
US11864575B2 (en) Composition comprising low temperature water extract of hibiscus manihot for anti-obesity
KR102453180B1 (en) Composition of enzyme food for improving obesity and skin wrinkle comprising Rhynchosia Nulubilis cheonggukjang and mucus from eel
KR101889856B1 (en) Method for producing Corni fructus extract with increased antioxidative activity using pressurized steaming
KR100887234B1 (en) Composition for preventing or improving diabetes induced complication containing phellinus baumii extract

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant